
Health Technology Assessment – Challenges and opportunities ...
Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster
Newsletters and Deep Dive digital magazine
Changes to Health Technology Assessment in Europe offer new opportunities to streamline processes and get innovative treatments to market faster
From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Since December 2022, and COP decision 15/9, members of the Convention on Biolog
We’re back this year, this time virtually attending the FT US Pharma and Biotech Summit in New York City, a one-day event where top pharma execs will come together to discuss the major tren
During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Editor's Picks
Newsletters and Deep Dive
digital magazine